Related Experiment Videos
Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy
P L Roberson1, R K Ten Haken, D L McShan
1Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor 48109.
Summary
Hepatic 90Y-microsphere therapy shows dose nonuniformity, sparing normal liver tissue. Three-dimensional dose calculations reveal significant tumor-to-normal-tissue dose ratios in rabbit VX2 models.
Area of Science:
- Hepatobiliary imaging and therapy
- Radiopharmaceutical dosimetry
- Medical physics
Background:
- Hepatic 90Y-microsphere therapy is a treatment for liver tumors.
- Dose deposition uniformity is crucial for therapeutic efficacy and normal tissue sparing.
- Understanding dose distribution is key to optimizing treatment outcomes.
Purpose of the Study:
- To investigate the impact of nonuniform dose deposition in hepatic 90Y-microsphere therapy.
- To perform 3D dose calculations for the VX2 tumor model in rabbits.
- To correlate microsphere distribution with dose gradients and tumor-to-normal-tissue ratios.
Main Methods:
- 3D dose calculations using a treatment planning system.
- Mimicking 90Y-microsphere deposition with colored spheres in a rabbit VX2 tumor model.
- Serial sectioning, imaging, and digitization of microsphere positions.
Main Results:
- A 2-mm liver tumor nodule received 15x more microspheres than normal liver.
- Calculated tumor-to-normal-tissue (TNT) dose ratios were 2.6 (average) and 1.9 (minimum).
- Significant dose gradients were observed, with minimum doses less than half the average dose.
Conclusions:
- Nonuniform microsphere distribution significantly impacts dose deposition in hepatic 90Y-microsphere therapy.
- The findings suggest that dose nonuniformity plays a critical role in normal liver tissue sparing.
- Further research is needed to reconcile calculated doses with known liver tolerance in uniform irradiation scenarios.